← Open Payments lookup

JAMIE ROGERS: Open Payments

NPI 1396081360 · MENIFEE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,143 in 34 payments from 11 companies in 2025. Trend: 2023 $17 · 2024 $122 · 2025 $1,143

Food & beverage: $1,143
CompanyPaymentsAmount
Amgen Inc.11$410
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$186
Novo Nordisk Inc4$175
Neurocrine BioSciences, Inc.2$140
Lundbeck LLC5$70
Corcept Therapeutics2$38
GlaxoSmithKline, LLC.2$34
Lilly USA, LLC1$30
Otsuka America Pharmaceutical, Inc.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21

Products named: Repatha, XIFAXAN, OTEZLA, INGREZZA, Ozempic, REXULTI, Korlym, TRELEGY ELLIPTA.

Industry payments across CA — which companies pay providers there.